| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f84ca82b162bb3666224f69c02dd88c3 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M2230-207
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-342 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-26
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61M1-367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G06F19-3437
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16Z99-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H50-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G16H20-40 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61M1-36
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-40
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G16H20-17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K33-26 |
| filingDate |
2013-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4988d50f798587e74d1017d4dcc4f2d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cd9ffb51438789fd5b5be5d87ad9905d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92f53c34cc6a0148044b41216466d8b7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f03de5101ae0ca32c95983276d911fc2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fd3c766a31e5b197da583a6a246d0e57 |
| publicationDate |
2014-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2014128791-A1 |
| titleOfInvention |
System and Method of Modeling Erythropoiesis Including Iron Homeostasis |
| abstract |
A method of adjusting a patient's undesired hematocrit and/or hemoglobin concentration to a value within a desired range at a predetermined time with an erythropoiesis stimulating agent (ESA) regimen includes obtaining patient parameters required for input into a model for predicting the patient's hematocrit and/or hemoglobin concentration at a predetermined time with a selected ESA administration regimen, the model including iron homeostasis, and employing the patient parameters and an initially selected ESA administration regimen in the model to predict the patient's hematocrit and/or hemoglobin concentration at the predetermined time with the initially selected ESA administration regimen. The method then includes administering ESA to the patient with an ESA administration regimen predicted to adjust the patient's hematocrit and/or hemoglobin concentration to the desired range at the predetermined time. The method can be implemented in a hemodialysis system. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107251028-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11295866-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2016180053-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3686603-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11467170-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10319478-B2 |
| priorityDate |
2012-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |